AEON Biopharma (AEON) Depreciation & Amortization (CF) (2022 - 2025)
AEON Biopharma (AEON) posted Depreciation & Amortization (CF) of $20000.0 for Q4 2025, up 5.26% sequentially from $19000.0 in Q3 2025, and down 13.04% YoY from $23000.0 in Q4 2024.
AEON Biopharma (AEON) Depreciation & Amortization (CF) (2022 - 2025) Analysis & Trends
AEON Biopharma has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $20000.0 in Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 13.04% year-over-year to $20000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $78000.0 (up 8.33% YoY) and the FY2025 annual result came in at $78000.0, down 19.59% from the prior year.
- Depreciation & Amortization (CF) advanced to $20000.0 in Q4 2025 per AEON's latest filing, from $19000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $32000.0 in Q4 2022 and troughed at $19000.0 in Q1 2025.
- A 4-year average of $22800.0 and a median of $22000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) changed 0.0% in 2024, then fell 24.0% in 2025.
- Over 4 years, Depreciation & Amortization (CF) stood at $32000.0 in 2022, then plunged by 34.38% to $21000.0 in 2023, then climbed by 9.52% to $23000.0 in 2024, then retreated by 13.04% to $20000.0 in 2025.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $20000.0, $19000.0, and $20000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2022 | 32,000.00 |